Well Health Tech Stock Price, News & Analysis

WELLSTAR Technologies, a subsidiary of WELL Health Technologies (TSX:WELL, OTCQX:WHTCF), has launched Nexus AI, a Canadian-built artificial intelligence platform for healthcare providers. The platform features advanced ambient scribe capabilities and integrates with Canadian EMR systems to streamline clinical workflows and reduce administrative burden.

Developed by physicians and AI researchers from the University of Toronto and HEALWELL AI, Nexus AI is already being used by thousands of providers across 20 specialties in Canada. The platform will expand to include disease detection, medical coding, billing automation, and clinical decision support features. Notably, Nexus AI is participating in Canada Health Infoway's AI Scribe Program, which will fund one-year licenses for up to 10,000 eligible primary care clinicians.

WELL Health Technologies (TSX: WELL) has rebranded its cybersecurity division as 'CYBERWELL', consolidating four trusted cybersecurity businesses - Source44, SeekIntoo, Cycura, and Proack Security - into a unified data protection platform. The company has appointed Jeffrey Engle, a seasoned cybersecurity executive and U.S. special operations veteran, as CEO to lead the division. Under Engle's leadership, CYBERWELL will focus on driving growth through recurring revenue, disciplined acquisitions, and international expansion, particularly targeting healthcare and critical infrastructure sectors. The strategic consolidation aims to enhance operational efficiency, strengthen brand equity, and position WELL to better serve the growing demand for advanced cybersecurity capabilities across North America and beyond. WELL indicates that CYBERWELL may be considered for a future spinout, potentially creating additional shareholder value.

WELL Health Technologies (TSX: WELL, OTCQX: WHTCF) has scheduled the release of its Fourth Quarter and Year End 2024 financial results on April 14, 2025, after market close. The digital healthcare company will host a conference call and webcast to discuss the results on April 15, 2025, at 1:00 PM ET (10:00 AM PT).

The earnings call will be led by Chairman and CEO Hamed Shahbazi and CFO Eva Fong. Participants can join through various dial-in options, including local Toronto (437-900-0527), Vancouver (604-259-0841), North American toll-free (1-888-510-2154), and international lines.

WELL Health Technologies (TSX: WELL, OTCQX: WHTCF) has received a Management Cease Trade Order (MCTO) from the British Columbia Securities Commission following a delay in filing its Annual Filings for the year ended December 31, 2024. The MCTO restricts the CEO and CFO from trading company securities until the required documents are filed.

The Annual Filings include the company's annual information form, audited annual financial statements, and management's discussion and analysis. During this period, the company has committed not to issue or acquire securities from insiders or employees. The MCTO does not affect non-insider shareholders' ability to trade.

The company will provide bi-weekly default status reports and announce completion once the Annual Filings are submitted to SEDAR+.

WELL Health Technologies Corp. (WHTCF) has exercised its call option rights to acquire significant shares in HEALWELL AI Inc. The transaction occurred concurrent with HEALWELL's acquisition of Orion Health Holdings for approximately NZ$175 million on April 1, 2025.

Through the exercise of the Call Right, WELL acquired 30.8 million Subordinate Voting Shares and 30.8 million Multiple Voting Shares from HEALWELL's founding shareholders. Following the transaction, WELL now owns 97,473,161 HEALWELL Shares and 30,800,000 Multiple Voting Shares, representing approximately 37% of the economic interest and 69% of the voting rights in HEALWELL on a partially-diluted basis.

WELL Health Technologies Corp. (WHTCF) has announced its intention to exercise a call option to acquire shares in HEALWELL AI Inc. concurrent with HEALWELL's acquisition of Orion Health Holdings The call option allows WELL to purchase up to 30.8 million Subordinate Voting Shares and 30.8 million Multiple Voting Shares from HEALWELL's founding shareholders at $0.125 and $0.0001 per share respectively.

HEALWELL is set to acquire Orion Health for approximately NZ$175 million, with closing anticipated on April 1, 2025. Following the exercise of the call right and the Orion Health acquisition, WELL is expected to own approximately 37% of the economic interest and 69% of the voting rights in HEALWELL on a partially-diluted basis. WELL was previously approved as a control person of HEALWELL by shareholders and the Toronto Stock Exchange.

WELL Health Technologies (TSX: WELL, OTCQX: WHTCF) has reported record patient visits for fiscal year 2024, achieving 5.7 million total patient visits, representing a significant 32% year-over-year growth, with organic growth accounting for 30%.

The company's Canadian patient services business demonstrated exceptional performance, recording 3.125 million patient visits, marking a 35% year-over-year increase. The organic growth in Canadian operations was particularly strong at 32%, comprised of 26% same clinic sales growth and 6% absorption growth.

These preliminary operational results highlight WELL's success in leveraging its technology-enabled care model to drive strong organic growth across its enterprise, particularly in its Canadian Clinics division.

WELL Health Technologies (TSX: WELL, OTCQX: WHTCF) announces plans to acquire a majority controlling interest in HEALWELL AI concurrent with HEALWELL's proposed acquisition of Orion Health on April 1, 2025. Following the exercise of its call right, WELL will hold approximately 37% economic interest and 69% voting interest in HEALWELL on a non-diluted basis.

WELL has exercised all 20.3M share purchase warrants and converted all HEALWELL convertible debentures, acquiring 43.3M additional Class A shares. The company expects HEALWELL to contribute approximately $160 million in revenue with positive Adjusted EBITDA to WELL's consolidated financial statements over the next 12 months.

HEALWELL's acquisition of Orion Health, valued at approximately $175 million, will provide access to Orion's global customer base serving 150 million lives worldwide. Orion Health is expected to generate over $100 million in revenues mostly from subscription licenses and services with strong double-digit Adjusted EBITDA margins.

WELL Health Technologies (TSX: WELL, OTCQX: WHTCF) has announced a delay in filing its 2024 audited annual financial statements beyond the March 31, 2025 deadline. The delay stems from accounting implications related to its subsidiary Circle Medical Technologies, which is under investigation by the U.S. Attorney's Office regarding certain billing practices.

Circle Medical, which contributed a net loss of $1.1 million to WELL's consolidated net income of $16.6 million in 2023 and less than 2.7% to consolidated Adjusted EBITDA, received a request for voluntary production of documents in September 2024. WELL expects to file the required documents by April 15, 2025, and has applied for a management cease trade order during this period.

The company states that the resolution is not expected to materially affect its cash position and confirms it continues to seek strategic alternatives for Circle Medical.